AH6809 antagonizes non-small cell lung cancer prostaglandin receptors

Lung Cancer

Volumn 36, Issue 1, 2002, Pages 33-42

  Casibang, Marchessini ^a   Moody, Terry W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AH6809; NSCLC; PGE2; Proliferation; Receptor binding

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; CALCIUM ION; CYCLIC AMP; LEUKOTRIENE B4; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROTEIN C FOS; TRITIUM;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEMBRANE BINDING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036120930     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00476-7     Document Type: Article

References (40)

1. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer
2. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro
3. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line
4. A novel VIP antagonist inhibits non-small cell lung cancer growth
5. Peptides and growth factors in non-small cell lung cancer
6. Prostaglandin endoperoxide synthetases
7. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling
8. Lipoxygenase inhibitors as lung cancer chemopreventive agents
9. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors
10. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs
11. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
12. 2 increases vascular endothelial cell growth factor mRNAs in lung cancer cells
13. 1 subtype
14. 3 receptors: Evidence of three variants with differing carboxyl termini
15. 2 prostanoid receptor
16. 2 subtype
17. Establishment and identification of small cell lung cancer cell lines having classic and variant features
18. 2 subtype
19. Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer
20. Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells
21. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells
22. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
23. 13,14)Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo
24. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist TR4979
25. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors
26. 2 type
27. Characterization of EP prostanoid receptor subtypes in primary cultures of bovine ciliary epithelial cells by immunofluorescent microscopy and functional studies
28. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
29. Human prostanoid receptors: Cloning and characterization
30. Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors
31. Aspirin use and reduced risk of fatal cancer
32. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
33. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
34. Δ716 knockout mice by inhibition of cylooxygenase 2 (COX-2)
35. 1 in colon carcinogenesis
36. Comparative carcinogenecity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues
37. Inhibition of lung tumorigenesis by sulindac: Comparison of two experimental protocols
38. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
39. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
40. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms